Adhithya Sankar

@adhithyasankar.bsky.social

Endocrinologist. Salford Royal Hospital, UK. Previously @UoM. Dad, hiker and nature lover 🏞️

Peri-operative management of GLP-1 RAs & SGLT2 inhibitors❗️ 🔹 New 🇬🇧 consensus: GLP-1 RAs can continue, but risks of aspiration must be assessed. 🔸SGLT2i should be stopped 1 day pre-op to avoid euglycemic DKA. ❗️shared decision-making & tailored approaches to optimise safety. 🔗 ggdocs.co/4r995z

Bild

🧵 Cancer Cachexia and the Brain Stem (a thread) In NEJM, Groarke et al. report the results of a phase 2 clinical trial of ponsegromab therapy for cancer cachexia in patients with elevated humoral levels of growth differentiation factor 15 (GDF-15). nej.md/3XE645a 1/10 #MedSky #ScienceSky

Honey, stop what you're doing, new hyponatremia research just dropped! What's it say? It looks like slow correction is associated with worse outcomes, like death and length of stay! Was it just a small study? No, it was a meta-analysis of almost 12,000 patients! jamanetwork.com/journals/jam...

Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia

This systematic review and meta-analysis evaluates the association of sodium correction rates with mortality among hospitalized adults with severe hyponatremia.

jamanetwork.com